The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Acute Lymphoblastic Leukemia.
Phase of Trial: Phase I
Latest Information Update: 03 Jan 2018
At a glance
- Drugs Anti-CD19 CAR-transduced T cells (Primary) ; Cyclophosphamide; Fludarabine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 28 Dec 2017 Planned End Date changed from 1 Jul 2019 to 1 Dec 2019.
- 28 Dec 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Jul 2019.
- 11 Oct 2016 New trial record